- Home
- PGRU vs RLAY Comparison
PGRU vs RLAY Comparison
Compare PGRU & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGRU
- RLAY
- Stock Information
- Founded
- PGRU 2006
- RLAY 2015
- Country
- PGRU Singapore
- RLAY United States
- Employees
- PGRU N/A
- RLAY N/A
- Industry
- PGRU EDP Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PGRU Technology
- RLAY Health Care
- Exchange
- PGRU Nasdaq
- RLAY Nasdaq
- Market Cap
- PGRU 1.1B
- RLAY 1.1B
- IPO Year
- PGRU N/A
- RLAY 2020
- Fundamental
- Price
- PGRU $6.63
- RLAY $6.64
- Analyst Decision
- PGRU Buy
- RLAY Strong Buy
- Analyst Count
- PGRU 2
- RLAY 9
- Target Price
- PGRU $7.00
- RLAY $20.75
- AVG Volume (30 Days)
- PGRU 279.3K
- RLAY 1.7M
- Earning Date
- PGRU 11-19-2024
- RLAY 10-31-2024
- Dividend Yield
- PGRU N/A
- RLAY N/A
- EPS Growth
- PGRU N/A
- RLAY N/A
- EPS
- PGRU N/A
- RLAY N/A
- Revenue
- PGRU $116,419,914.00
- RLAY $35,208,000.00
- Revenue This Year
- PGRU $14.24
- RLAY N/A
- Revenue Next Year
- PGRU $18.14
- RLAY N/A
- P/E Ratio
- PGRU N/A
- RLAY N/A
- Revenue Growth
- PGRU 9.47
- RLAY 3637.58
- 52 Week Low
- PGRU $3.15
- RLAY $5.70
- 52 Week High
- PGRU $6.64
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- PGRU 63.39
- RLAY 45.07
- Support Level
- PGRU $6.56
- RLAY $6.55
- Resistance Level
- PGRU $6.64
- RLAY $6.94
- Average True Range (ATR)
- PGRU 0.02
- RLAY 0.39
- MACD
- PGRU -0.01
- RLAY 0.02
- Stochastic Oscillator
- PGRU 66.67
- RLAY 43.29
About PGRU PropertyGuru Group Limited
PropertyGuru Group Ltd is a property technology company. The company provides digital property marketplaces to match buyers and tenants with sellers and landlords, digital marketing services for property agents and developers, SaaS-based sales process automation for property developers, a digital mortgage marketplace and brokerage, and property data consultancy services for banks, valuers and property developers. Their operating segments and reportable segments are each of its four marketplaces, Singapore, Vietnam, Malaysia and Other Asia, and Fintech and data services.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).